BDX vs EW
As of Sep 20, 2026, Becton Dickinson (BDX) scores 6.7/10 and Edwards Lifesciences (EW) 5.5/10 on AlphaStocks' five-model composite, so BDX scores higher. BDX trades 21% above its model fair value; EW trades 45% above its model fair value.
BDX
BECTON DICKINSON & CO
6.7
Consider Buy
$180.78
EW
Edwards Lifesciences Corp
5.5
Consider Buy
$88.26
BDX vs EW: Which is the Better Investment?
BECTON DICKINSON & CO (BDX) scores 6.7/10 while Edwards Lifesciences Corp (EW) scores 5.5/10 on AlphaStocks' composite model. BECTON DICKINSON & CO has the higher composite rating of Consider Buy. On a P/E basis, BECTON DICKINSON & CO trades at 31.1x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | BDX | EW |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 6.7/10▲ | 5.5/10 |
| Rating | Consider Buy▲ | Consider Buy |
| Price | $180.78 | $88.26 |
| P/E Ratio | 31.1▲ | 48.2 |
| ROE | 6.6% | 8.8%▲ |
| Market Cap | $51B | $51B |
| Fair Value | $149.03 | $61.06 |
| Dividend Yield | 2.7% | — |
| Sector Rank | #20 of 168▲ | #78 of 168 |
| Model Verdicts | ||
| Piotroski | Attractive | Attractive |
| Buffett | Strong▲ | Attractive |
| Graham | Caution | Neutral▲ |
| Lynch | Caution | Neutral▲ |
| Greenblatt | Strong▲ | Attractive |
Related comparisons
BDX vs EW: Which Stock Scores Higher?
BECTON DICKINSON & CO (BDX) and Edwards Lifesciences Corp (EW) are both in the Health Care sector. BDX currently leads with a composite score of 6.7/10 (Consider Buy) compared to EW's 5.5/10 (Consider Buy).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer